Data production methods for harmonized patent statistics : patentee sector allocation.

Patent documents are one of the most comprehensive data sources on technology development. As such, they provide a unique source of information to analyze and monitor technological performance. Patent indicators are now used by companies and by policy and government agencies alike to assess technological progress on the level of regions, countries, domains, and even specific entities such as companies, universities and individual inventors. In this paper, we develop an exhaustive sector assignment taxonomy to identifying whether patentees are companies (private business enterprise), universities and higher education institutions, or governmental agencies. The methodology that we have developed will be outlined and made fully transparent. It will be shown that the methodology proposed is effective both in terms of completeness (over 99% of the patent volume of both USPTO and EPO are assigned to discrete categories) and accuracy (99% of the assigned codes reflect the category correctly). At the same time, further improvements are considered both feasible and relevant. In order to ensure that such improvements are put into effect, EUROSTAT and its development partners (K.U.Leuven and SOGETI) have deliberately chosen to put the methodology into the public domain. This action is, in effect, an invitation to researchers and analysts to further build on the methodology and to improve it where feasible. When informed about such improvements, EUROSTAT and its partners will ensure that updates and refinements of the methodology as a whole are made available to the wider publicPatent; Patentee; Assignee; Applicant; Innovation; Indicator; Sector assignment; Institutional; EPO; USPTOEEPO; Agency; Investors; USPTO; Performance; Patent statistics;

Data production methods for harmonized patent statistics : patentee sector allocation

Patent documents are one of the most comprehensive data sources on technology development. As such, they provide a unique source of information to analyze and monitor technological performance. Patent indicators are now used by companies and by policy and government agencies alike to assess technological progress on the level of regions, countries, domains, and even specific entities such as companies, universities and individual inventors. In this paper, we develop an exhaustive sector assignment taxonomy to identifying whether patentees are companies (private business enterprise), universities and higher education institutions, or governmental agencies. The methodology that we have developed will be outlined and made fully transparent. It will be shown that the methodology proposed is effective both in terms of completeness (over 99% of the patent volume of both USPTO and EPO are assigned to discrete categories) and accuracy (99% of the assigned codes reflect the category correctly). At the same time, further improvements are considered both feasible and relevant. In order to ensure that such improvements are put into effect, EUROSTAT and its development partners (K.U.Leuven and SOGETI) have deliberately chosen to put the methodology into the public domain. This action is, in effect, an invitation to researchers and analysts to further build on the methodology and to improve it where feasible. When informed about such improvements, EUROSTAT and its partners will ensure that updates and refinements of the methodology as a whole are made available to the wider publicPatent; Patentee; Assignee; Applicant; Innovation; Indicator; Sector assignment; Institutional; EPO; USPTOEstatus: publishe

The impact of academic technology: Do modes of involvement matter? The Flemish case

Patent statistics that reflect university technology development have become increasingly relevant as academia adopts entrepreneurial objectives while facing a trend toward more accountability. In this contribution, we focus on the patent activity of Flemish universities (period 1991–2001). In Flanders, university patenting has become explicitly incentivized through policy measures (1996) and more recently even resource allocation schemes are resulting in a notably high share of universities in the overall patent portfolio of the regional innovation system. As a result, one might expect inflationary effects on the level of academic patents, especially in terms of quality. In addition, we analyze whether the impact of academic patents depends on the mode of university involvement (university-invented vs university-owned). Overall, we observe a considerable increase in both types of academic patenting without any deterioration (over time) of citation rates. Moreover, our findings indicate that university-owned patents receive more forward citations than university-invented (firm-owned) patents. Combined, these findings signal that the increase of academic patent activity—stimulated by policies granting ownership rights to universities—did not coincide with a decrease in their value.status: publishe

Data production methods for harmonized patent statistics: Patentee sector allocation 2009

nrpages: 146status: publishe

Technometrie: Een mapping van het Vlaamse octrooilandschap

edition: 2015status: publishe

De Vlaamse technologiepositie: Analyse aan de hand van EPO-, USPTO- en PCT-octrooien

No ISSNedition: 2013status: publishe

The Impact of Legislative Framework Conditions on the Development of Stem Cell Technology: Assessment of National Innovation Systems

Stem cells have the potential to launch a newarea ofmedicine, curing deadly diseases with custom-made tissues and organs. But science and technology may have to take note of regulatory developments, which might impact if, how, and where that hope will be realized. Until now, no data have been available on the influence of national human stem cell research legislation on the technological activity in the field of stem cells. In this contribution, we assess whether legislative framework conditions affect technological activity in this field. Stem cell patent activity (US Patent and Trademark Office [USPTO]/European Patent Office [EPO]) and legislative framework conditions with respect to human stem cell research have been identified and characterized for the period 1997–2003 for 23 countries. For these countries, differences in human stem cell legislation coincide with differences in technological productivity.Where obtaining human stem cells from supernumerary embryos is permitted, higher levels of technological productivity for all types of stem cell research are observed.Amore permissive legislative approach to human therapeutic cloning coincides with greater emphasis on embryonic stem cell development activities in general. These findings suggest that technology trajectories are modulated by (national) legislative frameworks.status: publishe

Patent statistics at Eurostat: Methods for regionalisation, sector allocation and name harmonisation

nrpages: 72status: publishe

Vlaams Indicatorenboek 2019

Het Vlaams Indicatorenboek 2019 is een uitgave van het Expertisecentrum O&O Monitoring van de Vlaamse Gemeenschap in opdracht van de Vlaamse minister van Werk, Economie, Innovatie, en Sport en van de Vlaamse minister van Onderwijsstatus: publishe